Last reviewed · How we verify
NCT06971965: MAeSTro-TSH
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
NA trial testing Levothyroxin in Thyroid Cancer in 578 participants. Not yet recruiting.
31 December 2027
Quick facts
| Lead sponsor | National Cancer Center, Korea |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 578 |
| Start date | 2 June 2025 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2032 |
Drugs / interventions tested
- Levothyroxin — full drug profile →
Conditions studied
- Thyroid Cancer — all drugs for Thyroid Cancer →
- Papillary Thyroid Carcinoma — all drugs for Papillary Thyroid Carcinoma →
Sponsor
National Cancer Center, Korea
Who can join
Adults 19 to 79, any sex, with Thyroid Cancer or Papillary Thyroid Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a multicenter randomized controlled trial conducted in Korea. A parallel, two-group randomized design will be with thyroid stimulating hormone suppression therapy group(low TSH group; intervention) is different from the wIthout thyroid stimulating hormone (TSH) suppression therapy group(high TSH group; control).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06971965
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Levothyroxin
Trials testing the same drug.
- NCT06999278 — LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss · Phase 3 · not yet recruiting
- NCT06276205 — Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism · Phase 3 · completed
- NCT06527859 — Correlation Between Levothyroxine and Blood Th17/Treg in Pregnant Women With Normal-high TSH and Positive TPOAb · terminated
- NCT04734457 — Final Height in Patients With CH Diagnosed by the Screening · unknown
- NCT06547242 — Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration · Phase 1 · completed
Other recruiting trials for Thyroid Cancer
Currently open trials in the same condition.
- NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting
- NCT07370675 — Active Surveillance for Bethesda IV Thyroid Nodules · NA · recruiting
- NCT07389512 — Pharmaceutical Management in Targeted Radioligand Therapy · recruiting
- NCT07438847 — 177Lu-CTR-FAPI for the Treatment of Thyroid Cancer · Phase 1 · recruiting
- NCT07419932 — Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer · recruiting
Other National Cancer Center, Korea trials
Trials by the same sponsor.
- NCT07399561 — Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy · NA · not yet recruiting
- NCT07121478 — Patients With High-grade Pancreatic Neuroendocrine Tumors · Phase 2 · enrolling by invitation
- NCT07171528 — Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer · Phase 2 · recruiting
- NCT07125924 — Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer · NA · not yet recruiting
- NCT07041515 — Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06971965 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Center, Korea
- Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06971965.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing